AGP Executive Report
Last update: 38 minutes agoHemp policy shake-up: A new U.S. federal “total THC” standard is set to tighten the rules on intoxicating hemp products, with a Dec. 11 delay for most provisions but synthetic and lab-converted cannabinoids still facing an earlier ban—raising the stakes for retailers and insurers. Legal cannabis enforcement: Northwest Indiana saw cannabis arrests drop from 2021 to 2025 despite nearby adult-use legalization, showing enforcement patterns can shift even when state laws change. Industry spotlight: Dunbar Pharma will present dronabinol API supply capabilities at expopharm 2026 in Munich, focusing on batch consistency and long-term availability for compounded medicines. Cross-border drug cases: Nigeria’s NNPC disowned a truck linked to a 2,145kg cannabis bust, while NDLEA reports continued large-scale interceptions. Court developments: Malaysia’s appeal in a cannabis trafficking acquittal case hit a service snag, with Interpol tracing the defendant for prosecution’s next steps. Public debate: A New Hampshire lawmaker said she’d back federal cannabis legalization, arguing law enforcement resources should target major threats like opioids and cartels.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.